Key result
Lower 4D flow MRI-derived LPA vortex kinetic energy differentiates PAH from PVH.
Why the study?
Differentiating PAH from PVH is critical because treatments differ, but invasive right heart catheterization is required and noninvasive alternatives are needed.
Does 4D flow MRI-derived left pulmonary artery vortex energetics differentiate pulmonary arterial hypertension from pulmonary venous hypertension?
Case-Control (n=55)
Does 4D flow MRI-derived left pulmonary artery vortex energetics differentiate pulmonary arterial hypertension from pulmonary venous hypertension?
Absolute Event Rate: 37.14% vs 76.48%
p-value: p=<0.05
4D flow MRI-derived 3D vortex energetics in the left pulmonary artery shows promise as a noninvasive biomarker to differentiate pulmonary arterial hypertension from pulmonary venous hypertension.
4D flow MRI vortex energetics may aid noninvasive PAH-PVH differentiation; leaves open prospective validation before clinical adoption.
BACKGROUND: Pulmonary hypertension (PH) is a life-threatening. Differentiation pulmonary arterial hypertension (PAH) from pulmonary venous hypertension (PVH) is important due to distinct treatment protocols. Invasive right heart catheterization (RHC) remains the reference standard but noninvasive alternatives are needed. PURPOSE/HYPOTHESIS: To evaluate 4D Flow MRI-derived 3D vortex energetics in the left pulmonary artery (LPA) for distinguishing PAH from PVH. STUDY TYPE: Prospective case-control. POPULATION/SUBJECTS: Fourteen PAH patients (11 female) and 18 PVH patients (9 female) diagnosed from RHC, 23 healthy controls (9 female). FIELD STRENGTH/SEQUENCE: 1.5 T; gradient recalled echo 4D flow and balanced steady-state free precession (bSSFP) cardiac cine sequences. ASSESSMENT: LPA 3D vortex cores were identified using the lambda2 method. Peak vortex-contained kinetic energy (vortex-KE) and viscous energy loss (vortex-EL) were computed from 4D flow MRI. Left and right ventricular (LV, RV) stroke volume (LVSV, RVSV) and ejection fraction (LVEF, RVEF) were computed from bSSFP. In PH patients, mean pulmonary artery pressure (mPAP), pulmonary capillary wedge pressure (PCWR) and pulmonary vascular resistance (PVR) were determined from RHC. STATISTICAL TESTS: Mann-Whitney U test for group comparisons, Spearman's rho for correlations, logistic regression for identifying predictors of PAH vs. PVH and develop models, area under the receiver operating characteristic curve (AUC) for model performance. Significance was set at P < 0.05. RESULTS: PAH patients showed significantly lower vortex-KE (37.14 [14.68-78.52] vs. 76.48 [51.07-120.51]) and vortex-EL (9.93 [5.69-25.70] vs. 24.22 [12.20-32.01]) than PVH patients. The combined vortex-KE and LVEF model achieved an AUC of 0.89 for differentiating PAH from PVH. Vortex-EL showed significant negative correlations with mPAP (rho = -0.43), PCWP (rho = 0.37), PVR (rho = -0.64). In the PAH group, PVR was significantly negatively correlated with LPA vortex-KE (rho = -0.73) and vortex-EL (rho = -0.71), and vortex-KE significantly correlated with RVEF (rho = 0.69), RVSV, (rho = 0.70). In the PVH group, vortex-KE (rho = 0.52), vortex-EL significantly correlated with RVSV (rho = 0.58). DATA CONCLUSION: These preliminary findings suggest that 4D flow MRI-derived LPA vortex energetics have potential to noninvasively differentiate PAH from PVH and correlate with invasive hemodynamic parameters. EVIDENCE LEVEL: 1 TECHNICAL EFFICACY: Stage 3.
No takes yet. Share an insight, caveat, or question.
Elbaz et al. (2024) conducted a case-control in Pulmonary Hypertension (PAH vs. PVH) (n=55). 4D flow MRI-derived LPA vortex energetics (vortex-KE and vortex-EL) vs. Pulmonary venous hypertension (PVH) patients and healthy controls was evaluated on Peak systolic vortex-contained kinetic energy (vortex-KE) in μJ (p=<0.05). 4D flow MRI-derived left pulmonary artery vortex kinetic energy was significantly lower in PAH patients compared to PVH patients (37.14 μJ vs. 76.48 μJ), aiding in noninvasive differentiation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: